Skip to main content
. 2018 Mar 2;8:3929. doi: 10.1038/s41598-018-22054-w

Figure 7.

Figure 7

The metformin gel formulation modulates the ERK1/2 MAP kinase phosphorylation state in mice tumors. (A) Representative Western blots of extracts from MDA-MB-231 tumors developed in untreated control mice (CTR), in mice treated with metformin aqueous solution (MH Sol) or metformin-loaded gel (MH Gel), using the antibody against phospho-ERK1/2. Blots were stripped and reprobed with anti-α-tubulin antibody to normalize for differences in protein loading. (B) Densitometric analysis of Western blots performed in MDA-MB-231 tumors (n = 7). Values are reported as the means ± S.E.M. of densitometric measurement of the immunoreactive bands (ANOVA with Dunnett’s post-hoc test: n.s. = not significant, *p < 0.05).